Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

NCT01744171 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Study was Suspended since 2018; PI decided to terminate.

Conditions

Recurrent Melanoma
Stage IIIB Skin Melanoma
Stage IIIC Skin Melanoma
Stage IV Skin Melanoma

Interventions

BIOLOGICAL: Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
OTHER: Laboratory Biomarker Analysis

Sponsor

Roswell Park Cancer Institute